Media Update, page-272

For those interested - Atomo article via LinkedIn:

“We were pleased to read this morning that at-home COVID19 rapid antigen testing has received support from the United States’ Biden administration. This is a very positive signal of progress for antigen testing and we congratulate our peers on their success.Commenting on the news, our Managing Director and CEO, John Kelly said, “This is excellent news for Ellume and for rapid testing as well as being a significant validation of Australian innovation.More generally, the US government’s US $230m investment in rapid antigen testing positively indicates increased acceptance of rapid antigen testing and interest by the Biden government in efficiently improving accessibility to COVID-19 testing. It is encouraging to see the United States now leveraging all available tools in a science-based response to managing the pandemic.”
Read Article Here: https://lnkd.in/gQR_vXi.
”Atomo continues to lobby various channels within Australian federal and state government to encourage use of antigen testing as part of the solution in opening up our state borders and enabling further freedom to operate.”